scarlet1967 wrote: There are still focusing on “face to face” sales when the direction of most industries including commercializing pharmaceutical companies is going digital!!
“The first add-on, MyTherapy MS, debuted last week with 1,000 multiple sclerosis patients already using it through a trial in Germany. Smartpatient plans to expand the MS module to Europe and the US later while also lining up more disease-specific modules for asthma, psoriasis, rheumatoid arthritis and HIV for debut over the next few months.
Pharma is fantastic when it comes to drug developments, but they’re just not close enough to patients, they don’t have direct access to them,” he said, adding that learning came after working together and relying on pharma companies to handle distribution.
Pharma companies have spent years launching medication adherence and just information or even game-type apps, but with little long-term success. Patients hesitate for several reasons: the potential for overload — one app per medication could be a lot to manage — and a lingering lack of trust in pharma.
Still, people do want health apps. Thirty-eight percent of patients surveyed recently by the Organisation for the Review of Care and Health Apps (ORCHA) said they use health apps, and 87% agreed they were satisfied with the experience. Almost half (49%) said doctors should be able to prescribe health apps just like they do with traditional medicines.”
Mobile app developer adds disease-specific modules for patients – and pharma partners – Endpoints News